Acute lymphoblastic leukemia (ALL) is a cancer-specific lymphoid cell. Induction and
consolidation chemotherapy alone or in combination with different therapeutic approaches …

The recognition of the curative potential of the graft‐versus‐leukaemia effect for patients with
acute myeloid leukaemia (AML) undergoing stem cell transplantation, and the emergence of …

Since mid-1990s, the field of cancer immunotherapy has seen steady growth and selected
immunotherapies are now a routine and preferred therapeutic option of certain …

Recently, there has been remarkable progress in basic and preclinical studies of acute
myeloid leukemia (AML). The improved outcomes of AML can largely be attributed to …

Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically
heterogeneous disease, and its incidence is increasing as the population ages. Cytogenetic …

Immunotherapy has become a prominent strategy for the treatment of cancer. A method that
improves the immune system's ability to attack a tumor (Enhances antigen binding) …

Targeting of leukemic stem cells with specific immunotherapy would be an ideal approach
for the treatment of myeloid malignancies, but suitable epitopes are unknown. The …

In the last few years immunotherapy for malignant disease has moved into the mainstream
of therapeutic development. In the field of hematologic malignancies powerful antibody …

急性髓系白血病造血干细胞移植后复发的免疫治疗进展灣 Page 1 临床血液学杂志 棽棸棻椄年 斒
斆旍旈旑斎斿旐斸旚旓旍棬斆旇旈旑斸棭 棾棻卷椆期 急性髓系白血病造血干细胞移植 后复发的 …

Despite the success of CAR T-cell therapies in treating R/R B-NHL and R/R B-ALL, there are
still multiple challenges to overcome. The main problems arising from current CAR T-cell …